Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Mobocertinib succinate capsules approved for marketing with conditions

www.nmpa.comJanuary 11, 2023

Tag: Mobocertinib Succinate , Irreversible Tyrosine Kinase Inhibitor , innovative drug

PharmaSources Customer Service